114 related articles for article (PubMed ID: 15311585)
1. [Mutagen sensitivity in patients with multiple primary tumors (MPT) of the head and neck region--quantitative and qualitative assessment based on bleomycin assay].
Wierzbicka M; Jarmuz M; Gajecka M; Kujawski M; Szyfter W; Szyfter K
Otolaryngol Pol; 2004; 58(3):441-9. PubMed ID: 15311585
[TBL] [Abstract][Full Text] [Related]
2. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
3. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
4. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors.
Cloos J; Braakhuis BJ; Steen I; Copper MP; de Vries N; Nauta JJ; Snow GB
Int J Cancer; 1994 Mar; 56(6):816-9. PubMed ID: 7509776
[TBL] [Abstract][Full Text] [Related]
5. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
Cloos J; Snow GB; Braakhuis BJ
Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
[TBL] [Abstract][Full Text] [Related]
6. Mutagen sensitivity of patients with cancer at different sites of the head and neck.
Székely G; Remenár E; Kásler M; Gundy S
Mutagenesis; 2005 Sep; 20(5):381-5. PubMed ID: 16105906
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
8. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
[TBL] [Abstract][Full Text] [Related]
10. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
[TBL] [Abstract][Full Text] [Related]
11. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes.
Cloos J; Nieuwenhuis EJ; Boomsma DI; Kuik DJ; van der Sterre ML; Arwert F; Snow GB; Braakhuis BJ
J Natl Cancer Inst; 1999 Jul; 91(13):1125-30. PubMed ID: 10393720
[TBL] [Abstract][Full Text] [Related]
12. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay.
Lee JJ; Trizna Z; Hsu TC; Spitz MR; Hong WK
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):191-7. PubMed ID: 8833619
[TBL] [Abstract][Full Text] [Related]
13. Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection.
Albrecht T; Deng CZ; Abdel-Rahman SZ; Fons M; Cinciripini P; El-Zein RA
Environ Mol Mutagen; 2004; 43(3):169-78. PubMed ID: 15065204
[TBL] [Abstract][Full Text] [Related]
14. Increased mutagen sensitivity in patients with head and neck cancer is less pronounced in patients with nasopharyngeal carcinoma.
Ko JY; Lui LT; Sheen TS; Lou PJ; Hsu MM
Arch Otolaryngol Head Neck Surg; 1998 May; 124(5):578-81. PubMed ID: 9604986
[TBL] [Abstract][Full Text] [Related]
15. Non-random distribution of chromatid breaks in lymphocytes of laryngeal squamous cell carcinoma patients.
Gajecka M; Jarmuzs M; Szyfter W; Szyfter K
Oncol Rep; 2004 Jul; 12(1):153-7. PubMed ID: 15201977
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes.
Cloos J; de Boer WP; Snel MH; van den Ijssel P; Ylstra B; Leemans CR; Brakenhoff RH; Braakhuis BJ
Mol Cancer Res; 2006 Feb; 4(2):71-7. PubMed ID: 16513838
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-induced mutagen sensitivity, passive smoking, and risk of breast cancer in Chinese women: a case-control study.
Hu M; Han D; Sun S; Yan Y; Zhang J; Zhou Y
Cancer Causes Control; 2013 Apr; 24(4):629-36. PubMed ID: 23371556
[TBL] [Abstract][Full Text] [Related]
18. Does the bleomycin sensitivity assay express cancer phenotype?
Székely G; Remenár E; Kásler M; Gundy S
Mutagenesis; 2003 Jan; 18(1):59-63. PubMed ID: 12473736
[TBL] [Abstract][Full Text] [Related]
19. p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies.
Gallo O; Bianchi S; Giovannucci-Uzzielli ML; Santoro R; Lenzi S; Salimbeni C; Abbruzzese M; Alajmo E
Br J Cancer; 1995 May; 71(5):1008-12. PubMed ID: 7734291
[TBL] [Abstract][Full Text] [Related]
20. Mutagen sensitivity as a susceptibility marker for endometriosis.
Lin J; Zhang X; Chen Y
Hum Reprod; 2003 Oct; 18(10):2052-7. PubMed ID: 14507820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
